Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
RadioIsotope25
RadioIsotope25 Feb. 3 at 7:53 PM
$RADX When’s at $20 we won’t remember today
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 3 at 3:56 PM
$RADX Worth at least double today’s price. Market cap would only be $120 million… CATX at half a billion and AKTS over a billion. At $60 million this is. Diamond in the rough.
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 3 at 2:56 PM
Why RADX’s B7-H3 can upend Aktis Oncology’s in 2026… $AKTS $RADX $CATX
1 · Reply
biospeculator
biospeculator Feb. 3 at 1:04 PM
$RADX Based on current chart pattern, the ability to now buy on Schwab and other platforms without a broker, and upcoming news regarding RAD 101 and Her2, the stock is ready to run higher. Target is $16-$20. Remember board members that RADX established a limited ATM for such an event. A sale of RAD 101 would negate that need. Based on recent investments RAD 101 phase II completed results worth imo 250M. Current market cap 60M. GLTA
0 · Reply
PaulWalter
PaulWalter Feb. 3 at 12:46 PM
$RADX when lambo? jeez.
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 3 at 1:01 AM
$RADX https://assets.kpmg.com/content/dam/kpmgsites/uk/pdf/2024/12/leveraging-opportunities-in-radiopharm.pdf $AKTS RADX $CATX
0 · Reply
biospeculator
biospeculator Feb. 2 at 8:18 PM
$RADX I am buying size GLTA
2 · Reply
biospeculator
biospeculator Feb. 2 at 8:15 PM
$RADX Buying
0 · Reply
ZacksSCR
ZacksSCR Feb. 2 at 7:35 PM
$RADX Fiscal 1H:26 Activity and Cash Flows https://buff.ly/K30CR6c
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 2 at 6:20 PM
$LNTH Lantheus owns significant equity in both Radiopharm Theranostics and Perspective Therapeutics $CATX $RADX
1 · Reply
Latest News on RADX
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Jan 28, 2026, 7:00 AM EST - 6 days ago

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Jan 12, 2026, 7:00 AM EST - 22 days ago

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Dec 15, 2025, 11:59 AM EST - 7 weeks ago

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Dec 15, 2025, 7:00 AM EST - 7 weeks ago

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Oct 20, 2025, 7:30 AM EDT - 3 months ago

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Radiopharm Theranostics Limited - Special Call

Sep 2, 2025, 1:15 AM EDT - 5 months ago

Radiopharm Theranostics Limited - Special Call

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Jul 29, 2025, 7:30 AM EDT - 6 months ago

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Jul 22, 2025, 8:00 AM EDT - 7 months ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Jun 2, 2025, 8:00 AM EDT - 8 months ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

May 19, 2025, 8:00 AM EDT - 9 months ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Dec 30, 2024, 8:00 AM EST - 1 year ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Dec 20, 2024, 8:00 AM EST - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Sep 19, 2024, 12:00 PM EDT - 1 year ago

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

DB

RadioIsotope25
RadioIsotope25 Feb. 3 at 7:53 PM
$RADX When’s at $20 we won’t remember today
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 3 at 3:56 PM
$RADX Worth at least double today’s price. Market cap would only be $120 million… CATX at half a billion and AKTS over a billion. At $60 million this is. Diamond in the rough.
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 3 at 2:56 PM
Why RADX’s B7-H3 can upend Aktis Oncology’s in 2026… $AKTS $RADX $CATX
1 · Reply
biospeculator
biospeculator Feb. 3 at 1:04 PM
$RADX Based on current chart pattern, the ability to now buy on Schwab and other platforms without a broker, and upcoming news regarding RAD 101 and Her2, the stock is ready to run higher. Target is $16-$20. Remember board members that RADX established a limited ATM for such an event. A sale of RAD 101 would negate that need. Based on recent investments RAD 101 phase II completed results worth imo 250M. Current market cap 60M. GLTA
0 · Reply
PaulWalter
PaulWalter Feb. 3 at 12:46 PM
$RADX when lambo? jeez.
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 3 at 1:01 AM
$RADX https://assets.kpmg.com/content/dam/kpmgsites/uk/pdf/2024/12/leveraging-opportunities-in-radiopharm.pdf $AKTS RADX $CATX
0 · Reply
biospeculator
biospeculator Feb. 2 at 8:18 PM
$RADX I am buying size GLTA
2 · Reply
biospeculator
biospeculator Feb. 2 at 8:15 PM
$RADX Buying
0 · Reply
ZacksSCR
ZacksSCR Feb. 2 at 7:35 PM
$RADX Fiscal 1H:26 Activity and Cash Flows https://buff.ly/K30CR6c
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 2 at 6:20 PM
$LNTH Lantheus owns significant equity in both Radiopharm Theranostics and Perspective Therapeutics $CATX $RADX
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 2 at 3:21 PM
Why radiopharmaceuticals are becoming central to precision oncology $RADX $AKTS $CATX https://www.drugtargetreview.com/article/192528/why-radiopharmaceuticals-are-becoming-central-to-precision-oncology/
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 2 at 2:49 PM
$RADX CATX just raised $179 million this morning. Radiopharm is simmering $CATX $AKTS
0 · Reply
VolcanicTrades
VolcanicTrades Feb. 2 at 1:23 PM
$RADX hope you are considering adding some. This will be a 🌋. Data and cash. Strong setup for another portfolio changing move
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 1 at 8:28 PM
FDA broadens use of Novartis’ radiopharma drug Pluvicto | BioPharma Dive $RADX https://www.biopharmadive.com/news/pluvicto-novartis-fda-expand-approval-prostate-cancer-earlier/743890/
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 1 at 2:56 AM
A new way to see and treat cancer | Stanford Cancer Institute $RADX https://med.stanford.edu/cancer/about/news/a-new-way-to-see-and-treat-cancer.html
0 · Reply
trading_momentum_x
trading_momentum_x Feb. 1 at 2:11 AM
$RADX looking great here. Still accumulating in this range and attempted a breakout this week but retreated back to 4.80 support area. Ended over 5$ one again. Needs to build momentum and make a run over 6$ to enter a volume void
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 1 at 12:35 AM
RAD202 utilizes a nanobody to deliver Lu-177 New Nanoparticles Hold Promise for Radiopharmaceuticals Efficiency $RADX $ATNM $CLRB http://www.iaea.org/newscenter/news/new-nanoparticles-hold-promise-for-radiopharmaceuticals-efficiency
0 · Reply
VolcanicTrades
VolcanicTrades Jan. 31 at 3:48 PM
$RADX this setup provided 600% returns. 💰 Data rollout coming soon. Another 600%? 👀 @RadioIsotope25 putting this back on my radar
2 · Reply
trading_insight
trading_insight Jan. 31 at 3:56 AM
$RADX - a name to watch for a pop and fade play. Saw 26$ and now down to 5 with good support near 4.70. Large volume void above 6.50 so has plenty of room to run but price has been pinned below the 50&100dema during this range pattern. Would wait until price can close above those MAs and starting gaining volume and momentum
0 · Reply
alsworthg
alsworthg Jan. 31 at 12:07 AM
$RADX boy oh boy...patience is a necessity here. Lol
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 30 at 8:48 PM
$RADX If it’s not RADX or CATX it’s wrong
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 30 at 4:02 PM
$RADX Big Bang
0 · Reply